REYON Pharmaceutical Co., Ltd. (KRX:102460)

REYON Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 20, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	199,550	235,498	303,360	384,347	631,111	390,433
Market Cap Growth	-34.02%	-22.37%	-21.07%	-39.10%	61.64%	47.64%
Enterprise Value	405,250	381,553	498,164	550,681	726,725	401,156
Last Close Price	10880.00	12840.00	16540.00	21444.72	34972.84	21582.97
PE Ratio	-	56.73	84.66	52.23	116.61	101.56
PS Ratio	1.34	1.59	2.01	2.50	4.42	3.00
PB Ratio	0.86	0.94	1.22	1.55	2.57	1.70
P/TBV Ratio	0.86	0.95	1.23	1.56	2.59	1.71
P/OCF Ratio	-	-	35.09	44.03	54.01	84.89
EV/Sales Ratio	2.71	2.57	3.30	3.58	5.09	3.09
EV/EBITDA Ratio	-	71.21	76.00	61.31	117.02	64.51
EV/EBIT Ratio	-	-	281.00	123.81	470.45	242.53
EV/FCF Ratio	-42.87	-	-	-	-	-
Debt / Equity Ratio	0.92	0.82	0.91	0.85	0.85	0.26
Debt / EBITDA Ratio	181.50	38.08	34.33	23.40	33.38	9.56
Asset Turnover	0.31	0.30	0.31	0.32	0.36	0.44
Inventory Turnover	2.79	1.99	2.25	2.60	2.35	2.22
Quick Ratio	0.34	0.35	0.51	1.63	2.91	1.83
Current Ratio	0.60	0.66	0.80	2.27	3.47	2.42
Return on Equity (ROE)	-5.93%	1.67%	1.44%	3.02%	2.33%	1.70%
Return on Assets (ROA)	-3.35%	-0.12%	0.22%	0.58%	0.24%	0.35%
Return on Capital (ROIC)	-3.82%	-0.13%	0.24%	0.61%	0.26%	0.38%
Return on Capital Employed (ROCE)	-7.70%	-0.30%	0.50%	1.00%	0.40%	0.60%
Earnings Yield	-7.14%	1.76%	1.18%	1.93%	0.88%	0.98%
FCF Yield	-4.74%	-7.41%	-6.67%	-14.16%	-16.68%	-12.22%
Dividend Yield	-	-	0.91%	0.70%	0.71%	0.93%
Payout Ratio	-	66.27%	76.41%	61.38%	62.56%	150.47%
Buyback Yield / Dilution	-0.79%	-	-0.46%	-3.03%	-4.05%	-1.01%
Total Shareholder Return	-0.79%	-	0.45%	-2.33%	-3.34%	-0.09%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.